Parathyroid hormone response to vitamin D insufficiency in elderly: Males with chronic heart failure

Physiological Research

Volumn 60, Issue SUPPL.1, 2011, Pages

  Bozic, B ^a,b   Loncar, G ^c   Prodanovic, N ^a   Lepic, T ^a   Radojicic, Z ^b   Cvorovic, V ^d   Dimkovic, S ^c   Popovic, V ^e  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

^d Clinical Hospital Center Zemun   (Serbia)

^e CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Adiponectin; Bone markers; Heart failure; PTH; Response; Vitamin D insufficiency

Indexed keywords

ADIPONECTIN; ADIPONECTIN, HUMAN; BIOLOGICAL MARKER; COLLAGEN; GLUTAMYL LYSYL ALANYL HISTIDYL ASPARTYL GLYCYL GLYCYL ARGININE; GLUTAMYL-LYSYL-ALANYL-HISTIDYL-ASPARTYL-GLYCYL-GLYCYL-ARGININE; PARATHYROID HORMONE; PEPTIDE FRAGMENT; PTH PROTEIN, HUMAN; VITAMIN D;

AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BODY COMPOSITION; BONE DENSITY; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; EXERCISE TEST; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; HUMAN; HYPOPARATHYROIDISM; MALE; MIDDLE AGED; PHOTON ABSORPTIOMETRY; PROGNOSIS; QUESTIONNAIRE; RISK; RISK ASSESSMENT; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SERBIA; STATISTICAL MODEL; VITAMIN D DEFICIENCY;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY COMPOSITION; BONE DENSITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; COLLAGEN; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; HEART FAILURE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPOPARATHYROIDISM; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROGNOSIS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SERBIA; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84855183413     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ALSAFWAH S, LAGUARDIA S, ARROYO M, DOCKERY B, BHATTACHARYA S, AHOKAS R, NEWMAN K. Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res 5: 238-243, 2007.
2. ANKER SD, CHUA TP, PONIKOWSKI P, HARRINGTON D, SWAN JW, KOX WJ, POOLE-WILSON PA, COATS AJ. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96: 526-534, 1997.
3. ANKER SD, CLARK AL, TEIXEIRA MM, HELLEWELL PG, COATS AJ. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 83: 612-615, 1999.
4. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories Am J Respir Crit Care Med 166: 111-117, 2002.
5. BLEUMINK GS, KNETSCH AM, STURKENBOOM MC, STRAUS SM, HOFMAN A, DECKERS JW, WITTEMAN JC, STRICKER BH. Quantifying the heart failure epidemic: prevalence, incidence rate, life time risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25: 1614-1619, 2004.
6. BRAUNWALD E. Biomarkers in heart failure. N Engl J Med 358: 2148-2159, 2008.
7. CHEN JS, SAMBROOK PN, MARCH L, CAMERON ID, CUMMING RG, SIMPSON JM, SEIBEL MJ. Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf) 68: 290-298, 2008.
8. CHHOKAR VS, SUN Y, BHATTACHARYA SK, AHOKAS RA, MYERS LK, XING Z, SMITH RA, GERLING IC, WEBER KT. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111: 871-878, 2005.
9. COCKROFT DW, GAULT MH. Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976.
10. CORRETTI MC, ANDERSON TJ, BENJAMIN EJ, CELERMAJER D, CHARBONNEAU F, CREAGER MA, DEANFIELD J, DREXLER H, GERHARD-HERMAN M, HERRINGTON D, VALLANCE P, VITA J, VOGEL R. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265, 2002.
11. DEVEREUX RB, ROMAN MJ, DE SIMONE G, O'GRADY MJ, PARANICAS M, YEH JL, FABSITZ RR, HOWARD BV. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation 96: 1416-1423, 1997.
12. FISCHER D, ROSSA S, LANDMESSER U, SPIEKERMANN S, ENGBERDING N, HORNIG B, DREXLER H. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26: 65-69, 2005.
13. FORMAN JP, GIOVANNUCCI E, HOLMES MD, BISCHOFF-FERRARI HA, TWOROGER SS, WILLETT WC, CURHAN GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49: 1063-1069, 2007.
14. GANNAGÉ-YARED MH, FARES F, SEMAAN M, KHALIFE S, JAMBART S. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. Clin Endocrinol (Oxf) 64: 652-658, 2006.
15. GARAKYARAGHI M, KERDEGARI M, SIAVASH M. Calcium and vitamin D status in heart failure patients in Isfahan, Iran. Biol Trace Elem Res 135: 67-73, 2010.
16. ISAIA G, GIORGINO R, RINI GB, BEVILACQUA M, MAUGERI D, ADAMI S. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 14: 577-582, 2003.
17. KATZ SD, HRYNIEWICZ K, HRILJAC I, BALIDEMAJ K, DIMAYUGA C, HUDAIHED A, YASSKIY A. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111: 310-314, 2005.
18. KENNY AM, BOXER R, WALSH S, HAGER WD. Femoral bone mineral density in patients with heart failure. Osteoporos Int 17: 1420-1427, 2006.
19. LEE NK, SOWA H, HINOI E, FERRON M, AHN JD, CONFAVREUX C, DACQUIN R, MEE PJ, MCKEE MD, JUNG DY, ZHANG Z, KIM JK, MAUVAIS-JARVIS F, DUCY P, KARSENTY G. Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-469, 2007.
20. LEVY D, KENCHAIAH S, LARSON MG, BENJAMIN EJ, KUPKA MJ, HO KK, MURABITO JM, VASAN RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397-1402, 2002.
21. LIPS P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22: 477-501, 2001.
22. LONCAR G, BOZIC B, DIMKOVIC S, PRODANOVIC N, RADOJICIC Z, CVOROVIC V, PUTNIKOVIC B, POPOVIC V. Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. J Endocrinol Invest 34: e78-e85, 2011.
23. LUO XH, GUO LJ, YUAN LQ, XIE H, ZHOU HD, WU XP, LIAO EY. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309: 99-109, 2005.
24. MOSEKILDE L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 62: 265-281, 2005.
25. PIOVESAN A, MOLINERI N, CASASSO F, EMMOLO I, UGLIENGO G, CESARIO F, BORRETTA G. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50: 321-328, 1999.
26. PITTAS AG, LAU J, HU FB, DAWSON-HUGHES B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-2029, 2007.
27. PREMAOR MO, SCALCO R, DA SILVA MJ, FURLANETTO TW. Secondary hyperparathyroidism is associated with increased risk of hospitalization or death in elderly adults living in a geriatric institution. Gerontology 55: 405-410, 2009.
28. RECTOR TS, COHN JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 124: 1017-1025, 1992.
29. SAHOTA O, GAYNOR K, HARWOOD RH, HOSKING DJ. Hypovitaminosis D and "functional hypoparathyroidism"- the NoNoF (Nottingham Neck of Femur) study. Age Ageing 30: 467-472, 2001.
30. SAHOTA O, MASUD T, SAN P, HOSKING DJ. Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hips in patients with established osteoporosis. Clin Endocrinol (Oxf) 51: 217-221, 1999.
31. SAHOTA O, MUNDEY MK, SAN P, GODBER IM, HOSKING DJ. Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 17: 1013-1021, 2006.
32. SALEH FN, SCHIRMER H, SUNDSFJORD J, JORDE R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24: 2054-2060, 2003.
33. SHANE E, MANCINI D, AARONSON K, SILVERBERG SJ, SEIBEL MJ, ADDESSO V, MCMAHON DJ. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103: 197-207, 1997.
34. SILVESTRY FE, KERBER RE, BROOK MM, CARROLL JD, EBERMAN KM, GOLDSTEIN SA, HERRMANN HC, HOMMA S, MEHRAN R, PACKER DL, PARISI AF, PULERWITZ T, SEWARD JB, TSANG TS, WOOD MA. Echocardiography-guided interventions. J Am Soc Echocardiogr 22: 213-231, 2009.
35. SOUBERBIELLE JC, CORMIER C, KINDERMANS C, GAO P, CANTOR T, FORETTE F, BAULIEU EE. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 86: 3086-3090, 2001.
36. SUGIMOTO T, TANIGAWA T, ONISHI K, FUJIMOTO N, MATSUDA A, NAKAMORI S, MATSUOKA K, NAKAMURA T, KOJI T, ITO M. Serum intact parathyroid hormone levels predict hospitalization for heart failure. Heart 95: 395-398, 2009.
37. The Criteria Committee of the New York Heart Association Criteria for diagnosis and treatment of heart failure. Little, Brown and Company, 1994.
38. VIETH R, LADAK Y, WALFISH PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88: 185-191, 2003.